Kynam Capital Management, LP
- SEC CIK
- 0001907884
- 最新申報
- 2026/8/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/14 申報。只含多頭部位。
- 持股檔數
- 30
- 2021 年第 3 季沒有申報
- 總值
- $1.87 億
- 2021 年第 3 季沒有申報
Kynam Capital Management, LP 沒有申報 2021 年第 3 季的 13F，這一季的持倉沒辦法跟上一季比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GBTGlobal Blood Therapeutics, Inc. | COM | 992,949 | $2,906 萬 | 15.5% | – | – | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 670,093 | $2,093 萬 | 11.2% | – | – | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 956,165 | $2,093 萬 | 11.2% | – | – | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 1,016,857 | $1,150 萬 | 6.1% | – | – | 歷史 |
| BIIBBiogen Inc. | COM | 40,000 | $959.7 萬 | 5.1% | – | – | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 226,726 | $876.1 萬 | 4.7% | – | – | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 2,210,866 | $745.1 萬 | 4.0% | – | – | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 253,449 | $677.2 萬 | 3.6% | – | – | 歷史 |
| LQDALiquidia Corp | COM NEW | 1,366,836 | $665.6 萬 | 3.6% | – | – | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 573,699 | $662.6 萬 | 3.5% | – | – | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 287,934 | $569.2 萬 | 3.0% | – | – | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 182,103 | $565.2 萬 | 3.0% | – | – | 歷史 |
| FATEFate Therapeutics Inc | COM | 95,561 | $559.1 萬 | 3.0% | – | – | 歷史 |
| PCVXVaxcyte, Inc. | COM | 211,483 | $503.1 萬 | 2.7% | – | – | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,494,594 | $469.3 萬 | 2.5% | – | – | 歷史 |
| MRUSMerus N.V. | COM | 122,158 | $388.5 萬 | 2.1% | – | – | 歷史 |
| BNRBurning Rock Biotech Ltd | SPONSORED ADS | 382,464 | $364.5 萬 | 1.9% | – | – | 歷史 |
| ZGNXZogenix, Inc. | COM NEW | 205,800 | $334.4 萬 | 1.8% | – | – | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 293,799 | $275.0 萬 | 1.5% | – | – | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 239,041 | $269.2 萬 | 1.4% | – | – | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 304,901 | $254.0 萬 | 1.4% | – | – | 歷史 |
| CABACabaletta Bio, Inc. | COM | 644,583 | $244.3 萬 | 1.3% | – | – | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 34,816 | $243.5 萬 | 1.3% | – | – | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 683,619 | $207.8 萬 | 1.1% | – | – | 歷史 |
| Affimed N VN01045108 | COM | 364,033 | $200.9 萬 | 1.1% | – | – | – |
| Radius Health, Inc.750469207 | COM NEW | 194,082 | $134.3 萬 | 0.7% | – | – | – |
| COGTCogent Biosciences, Inc. | COM | 150,000 | $128.7 萬 | 0.7% | – | – | 歷史 |
| AKUSAkouos, Inc. | COM | 99,008 | $84.2 萬 | 0.5% | – | – | 歷史 |
| NGNENeurogene Inc. | COM | 147,000 | $70.9 萬 | 0.4% | – | – | 歷史 |
| GYREGyre Therapeutics, Inc. | COM NEW | 110,991 | $10.1 萬 | 0.1% | – | – | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。